Boletis I - Search Results

1

Biovigilance for the Quality and Safety of Medical Products of Human Origin.

Gkioka V, Tsirigotis P, Sarris M, Soulis S, Apostolou A, Noutsias M, Dimitriadis G, Kostakis A, Boletis I, Karabinis A. Gkioka V, et al. Among authors: boletis i. J Clin Med Res. 2018 Dec;10(12):857-867. doi: 10.14740/jocmr3549w. Epub 2018 Oct 30. J Clin Med Res. 2018. PMID: 30425757 Free PMC article. Review.

2

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.

Rossing P, Burgess E, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Gillard P, MacIsaac RJ, Wainstein J, Joseph A, Brinker M, Roessig L, Scott C, Bakris GL; FIDELIO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Apr 1;45(4):888-897. doi: 10.2337/dc21-1944. Diabetes Care. 2022. PMID: 35061867 Free PMC article. Clinical Trial.

3

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.

Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294. Diabetes Care. 2022. PMID: 35972218 Free PMC article. Clinical Trial.

4

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.

Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.

5

Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.

Farmakis D, Tromp J, Marinaki S, Ouwerkerk W, Angermann CE, Bistola V, Dahlstrom U, Dickstein K, Ertl G, Ghadanfar M, Hassanein M, Obergfell A, Perrone SV, Polyzogopoulou E, Schweizer A, Boletis I, Cleland JGF, Collins SP, Lam CSP, Filippatos G. Farmakis D, et al. Among authors: boletis i. Eur J Heart Fail. 2023 Jun;25(6):818-828. doi: 10.1002/ejhf.2833. Epub 2023 Apr 12. Eur J Heart Fail. 2023. PMID: 36974770

6

Impact of donor and recipient age difference on long-term allograft survival after living donor renal transplantation: analysis of 478 cases.

Kostakis ID, Moris DN, Barlas A, Bokos I, Darema M, Theodoropoulou E, Karaolanis G, Kostakis A, Boletis I, Zavos G. Kostakis ID, et al. Among authors: boletis i. Clin Transplant. 2013 Nov-Dec;27(6):838-43. doi: 10.1111/ctr.12219. Epub 2013 Aug 31. Clin Transplant. 2013. PMID: 23991890

7

Relationship of Changes in Cystatin-C With Serum Creatinine and Estimated Glomerular Filtration Rate in Kidney Transplantation.

Gompou A, Perrea D, Karatzas T, Bellos JK, Kastania AN, Boletis I, Kostakis A. Gompou A, et al. Among authors: boletis i. Transplant Proc. 2015 Jul-Aug;47(6):1662-74. doi: 10.1016/j.transproceed.2015.04.084. Transplant Proc. 2015. PMID: 26293031

8

A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients' Lives and Allografts.

Marinaki S, Tsiakas S, Korogiannou M, Grigorakos K, Papalois V, Boletis I. Marinaki S, et al. Among authors: boletis i. J Clin Med. 2020 Sep 16;9(9):2986. doi: 10.3390/jcm9092986. J Clin Med. 2020. PMID: 32947798 Free PMC article. Review.

9

Therapeutic Options for Recurrence of Primary Focal Segmental Glomerulonephritis (FSGS) in the Renal Allograft: Single-Center Experience.

Vallianou K, Marinaki S, Skalioti C, Lionaki S, Darema M, Melexopoulou C, Boletis I. Vallianou K, et al. Among authors: boletis i. J Clin Med. 2021 Jan 20;10(3):373. doi: 10.3390/jcm10030373. J Clin Med. 2021. PMID: 33498160 Free PMC article.

10

The Evolution of Living Donor Nephrectomy Program at A Hellenic Transplant Center. Laparoscopic vs. Open Donor Nephrectomy: Single-Center Experience.

Vernadakis S, Marinaki S, Darema M, Soukouli I, Michelakis IE, Beletsioti C, Zavvos G, Bokos I, Boletis IN. Vernadakis S, et al. Among authors: boletis in. J Clin Med. 2021 Mar 12;10(6):1195. doi: 10.3390/jcm10061195. J Clin Med. 2021. PMID: 33809339 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page